Alain H. Rook

17.0k total citations · 2 hit papers
209 papers, 11.4k citations indexed

About

Alain H. Rook is a scholar working on Dermatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Alain H. Rook has authored 209 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Dermatology, 105 papers in Immunology and 79 papers in Pathology and Forensic Medicine. Recurrent topics in Alain H. Rook's work include Cutaneous lymphoproliferative disorders research (146 papers), Lymphoma Diagnosis and Treatment (65 papers) and T-cell and Retrovirus Studies (62 papers). Alain H. Rook is often cited by papers focused on Cutaneous lymphoproliferative disorders research (146 papers), Lymphoma Diagnosis and Treatment (65 papers) and T-cell and Retrovirus Studies (62 papers). Alain H. Rook collaborates with scholars based in United States, United Kingdom and Switzerland. Alain H. Rook's co-authors include Henry Masur, Anthony S. Fauci, H. Clifford Lane, Gail Whalen, Stuart R. Lessin, Maureen Cassin, Eric C. Vonderheid, Ellen J. Kim, Benjamin R. Vowels and Jonathan Wolfe and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Alain H. Rook

203 papers receiving 10.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

1983 1.3k citations Alain H. Rook et al. profile →
Cytotoxic T Cells in Cytomegalovirus Infection

1982 501 citations Alain H. Rook et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alain H. Rook United States	55	5.5k	5.2k	3.8k	3.3k	2.1k	209	11.4k
Stefania Jabłońska Poland	55	1.7k 0.3×	2.2k 0.4×	3.3k 0.9×	3.1k 1.0×	1.1k 0.5×	261	8.9k
Hans Yssel France	60	8.8k 1.6×	873 0.2×	1.4k 0.4×	650 0.2×	2.3k 1.1×	154	13.5k
Michel Gilliet Switzerland	48	14.4k 2.6×	3.4k 0.7×	1.4k 0.4×	687 0.2×	2.8k 1.3×	114	18.4k
Daniel M. Knowles United States	57	3.1k 0.6×	712 0.1×	4.7k 1.2×	5.6k 1.7×	10.0k 4.7×	171	16.1k
Lynette A. Fouser United States	28	8.5k 1.6×	1.3k 0.2×	911 0.2×	939 0.3×	3.9k 1.8×	36	11.9k
Rosanne Spolski United States	50	10.2k 1.9×	935 0.2×	1.1k 0.3×	864 0.3×	3.4k 1.6×	90	13.5k
Serge Lebecque France	59	15.0k 2.7×	887 0.2×	1.5k 0.4×	733 0.2×	4.2k 2.0×	123	19.5k
Bijan Safai United States	35	2.8k 0.5×	653 0.1×	1.9k 0.5×	884 0.3×	1.7k 0.8×	115	7.5k
Hermann Herbst Germany	54	1.9k 0.3×	569 0.1×	2.0k 0.5×	2.8k 0.8×	3.8k 1.8×	207	10.1k
Hernán Valdez United States	43	2.5k 0.5×	2.0k 0.4×	1.4k 0.4×	364 0.1×	671 0.3×	154	7.1k

Countries citing papers authored by Alain H. Rook

Since Specialization

Citations

This map shows the geographic impact of Alain H. Rook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain H. Rook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain H. Rook more than expected).

Fields of papers citing papers by Alain H. Rook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain H. Rook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain H. Rook. The network helps show where Alain H. Rook may publish in the future.

Co-authorship network of co-authors of Alain H. Rook

This figure shows the co-authorship network connecting the top 25 collaborators of Alain H. Rook. A scholar is included among the top collaborators of Alain H. Rook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain H. Rook. Alain H. Rook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Xiaowei, John N. Lukens, Tillman Pearce, et al.. (2025). Preliminary evaluation of the safety and feasibility of toll-like receptor ligand CB101 combined with hypofractionated radiation therapy in canine head and neck cancer: a pilot study. PubMed. 2(1). 18–18.

Sussman, Jonathan, Colin Thomas, Daniel J. Landsburg, et al.. (2025). Pembrolizumab in Relapsed or Refractory Mycosis Fungoides or Sézary Syndrome. JAMA Dermatology. 161(6). 656–656.

Kuramitsu, Shunichiro, Tong Da, Sangya Agarwal, et al.. (2023). Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma. Blood Advances. 7(14). 3416–3430. 27 indexed citations

Durgin, Joseph S., et al.. (2023). Reversible cardiomyopathy after interferon-gamma for cutaneous T cell lymphoma: A report of two cases. SHILAP Revista de lepidopterología. 11. 100255–100255.

Rastogi, Supriya, Daniel J. Lewis, Leah Cohen, et al.. (2023). Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T‐Cell Lymphoma. Dermatologic Therapy. 2023(1). 2 indexed citations

Shaw, Lauren, Mathilde Poussin, Alba Rodríguez-García, et al.. (2022). TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones. Blood Advances. 7(9). 1885–1898. 5 indexed citations

Zhao, Lei, Connor J. Stonesifer, Jay Daniels, et al.. (2022). The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell Lymphoma Can Be Reproduced by ΔNp73 Depletion. Journal of Investigative Dermatology. 142(12). 3253–3261.e4. 2 indexed citations

Guitart, Joan, Maria Estela Martínez‐Escala, Antonio Subtil, et al.. (2017). Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas. Modern Pathology. 30(5). 761–772. 59 indexed citations

Rook, Alain H., et al.. (2016). Topical Carmustine as Monotherapy or as Multimodality Therapy for Folliculotropic Mycosis Fungoides. Acta Dermato Venereologica. 97(3). 373–374. 9 indexed citations

10.

Rook, Alain H., Joel M. Gelfand, Maria Wysocka, et al.. (2015). Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma. Blood. 126(12). 1452–1461. 164 indexed citations

11.

Kim, Ellen J., Youn H. Kim, Alain H. Rook, et al.. (2015). Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphoma. Leukemia & lymphoma. 56(10). 2847–2854. 17 indexed citations

12.

Whittaker, Sean, Marie‐France Demierre, Ellen J. Kim, et al.. (2010). Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma. Journal of Clinical Oncology. 28(29). 4485–4491. 480 indexed citations

13.

Höeller, Christoph, Stephen K. Richardson, Lai Guan Ng, et al.. (2009). In vivo Imaging of Cutaneous T-Cell Lymphoma Migration to the Skin. Cancer Research. 69(7). 2704–2708. 16 indexed citations

14.

Kim, Ellen J., Stephen D. Hess, Stephen K. Richardson, et al.. (2005). Immunopathogenesis and therapy of cutaneous T cell lymphoma. Journal of Clinical Investigation. 115(4). 798–812. 310 indexed citations

15.

Shane, Ryan, Klára Berencsi, Éva Gönczöl, et al.. (2000). Chlamydia pneumoniae Inhibits Apoptosis in Human Peripheral Blood Mononuclear Cells Through Induction of IL-10. The Journal of Immunology. 164(10). 5522–5529. 103 indexed citations

16.

Showe, Louise C., et al.. (1999). Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4.. PubMed. 163(7). 4073–9. 42 indexed citations

17.

Cooper, Kevin D., Kyeongah Kang, Marek Kubin, Giorgio Trinchieri, & Alain H. Rook. (1994). Opposing cytokine production by normal Langerhans cells (IL-12) and UV-induced macrophages (IL-10). Journal of Investigative Dermatology. 103(3). 434. 1 indexed citations

18.

Lessin, Stuart R., Alain H. Rook, & G Rovera. (1991). Molecular Diagnosis of Cutaneous T-Cell Lymphoma: Polymerase Chain Reaction Amplification of T-Cell Antigen Receptor β-Chain Gene Rearrangements. Journal of Investigative Dermatology. 96(3). 299–302. 61 indexed citations

19.

Rook, Alain H.. (1976). Scleroderma and Pseudoscleroderma. BMJ. 2(6034). 534.3–534. 23 indexed citations

20.

Rook, Alain H., et al.. (1957). Familial granuloma annulare; report of two cases, with observations on the incidence of the disease in Britain.. PubMed. 37(2). 160–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact